• SENSEX 78,890.97
    1,589.57 (+2.06%)
  • BANKNIFTY 55,913.60
    373.55 (+0.67%)
  • NSE
    1,850.00 1,878.00(%)
  • ITC
    277.30 252.80(%)
  • Tube Investments
    2,227.65 2,006.00(%)
  • Axis Bank
    1,274.70 1,418.30(%)
  • Reliance Industries
    1,325.00 1,611.20(%)
  • HDFC Life Insur.
    546.00 788.50(%)
  • Aurobindo Pharma
    1,748.85 1,739.95(%)
  • Lenskart Solut.
    767.40 725.00(%)
  • HDFC Bank
    762.80 1,017.90(%)
  • Titan Company
    4,858.90 5,187.45(%)
  • Petronet LNG
    320.00 326.40(%)
  • Jio Platforms
    1,442.00 1,490.00(%)
  • CG Power & Ind
    812.40 525.50(%)
  • Tonbo Imaging
    1,460.00 1,343.80(%)
  • Larsen & Toubro
    4,071.00 4,440.00(%)
  • Multi Comm. Exc.
    3,395.00 3,537.00(%)
  • Saregama India
    613.80 305.65(%)
  • Bajaj Finance
    1,055.80 1,177.60(%)
  • Cummins India
    4,036.95 3,883.30(%)
  • Bajaj Auto
    10,750.10 12,470.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Cian Healthcare Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 74131.0
  • ISIN : INE05BN01027
34.83 1 (1.99%)
  • As on 05 Nov 2026 (EOD)

  • Today’s Low

    34.83

  • Today’s High

    34.83

  • Open

    34.83

  • Perv Close

    34.15

  • 52W Low

    4.72

  • 52W High

    34.83

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    87.08

  • Div & Yield %

    0.00

  • Book Value(₹)

    8.24

  • Debt-Equity Ratio

    1.99

  • AGM Date

    04-Nov-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    1.01

  • Mar.Cap (₹Cr.)

    87.08

  • RONW (%)

    1.33

  • ROCE (%)

    4.65

Score Board

  • Equity (₹ in Cr.)

    25.00

  • BV (₹)

    8.20

  • Sales( ₹ in Cr.)

    28.30

  • NP (in Cr.)

    -7.79

  • NP Var(%)

    -5.0

  • Div%

    0.0

  • CPS (₹)

    -2.30

  • EPS (₹)

    -3.10

  • Traded Value (₹ in Lakhs)

    87.08

  • 52 Week High

    34.83

  • 52 Week Low

    4.72

  • Price BSE

    35.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    87.08

  • P/C Ratio

    -15.40

  • P/E Ratio

    -11.20

  • Price Vs.BV

    -3.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 28.30 30.88 58.75 67.56 64.10 72.38
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 28.30 30.88 58.75 67.56 64.10 72.38
Other Income 1.40 -0.83 1.06 0.65 0.48 0.21
Stock Adjustments -5.64 -0.23 1.62 4.85 6.96 1.28
Total Income 24.06 29.82 61.43 73.06 71.54 73.87
EXPENDITURE :            
Raw Materials 16.89 20.06 35.65 45.80 45.20 44.19
Power and Fuel Cost 0.81 1.02 1.00 0.07 0.06 0.05
Employee Cost 5.87 6.51 7.18 7.76 7.72 6.44
Other Manufacturing Expenses 2.48 2.71 3.79 4.51 5.96 6.78
Selling and Administration Expenses 2.32 2.36 4.22 3.58 4.32 4.24
Miscellaneous Expenses 13.97 12.06 0.96 1.71 2.84 2.65
Employee Benefit Expenses 5.87 6.51 7.18 7.76 7.72 6.44
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 42.33 44.73 52.80 63.42 66.10 64.35
Operating Profit -18.27 -14.91 8.62 9.63 5.44 9.52
Interest 0.51 2.16 4.93 4.79 5.25 6.40
Gross Profit -18.78 -17.07 3.69 4.84 0.19 3.12
Depreciation 2.13 2.61 3.68 3.64 2.57 2.45
Profit Before Tax -20.91 -19.68 0.01 1.20 -2.38 0.67
Current Tax 0.00 -0.04 -0.19 0.20 0.00 0.41
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.11 0.02 -0.19 -0.08 -0.10 -0.07
Reported Net Profit -21.02 -19.66 0.39 1.08 -2.28 0.33
Extraordinary Items -13.23 -12.24 0.00 0.03 -0.07 -0.08
Adjusted Net Profit -7.79 -7.42 0.39 1.05 -2.21 0.41
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward -18.65 1.00 0.62 -0.46 1.81 1.49
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -39.67 -18.65 1.00 0.62 -0.46 1.81
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -8.41 -7.86 0.16 0.43 -0.91 0.14
Earnings Per Share(Adj)-Unit Curr - -7.86 0.16 0.43 -0.91 0.14
Book Value 8.24 16.86 24.73 24.57 24.14 25.62
Book Value(Adj)-Unit Curr - 16.86 24.73 24.57 24.14 25.62

Shareholding Pattern

  • Promoter Group

    95.00%

  • Public Share Holding

    5.00%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 4,750,000 4,750,000.00 4,750,000 4,750,000
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 4,750,000 19.00 4,750,000 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 13,750,000 55.00 13,750,000 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 5,250,000 21.00 5,250,000 1
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 19,000,000 76.00 19,000,000 2
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 96,721 0.39 96,721 19
Clearing Members 959 0.00 959 3
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 28,119 0.11 28,119 18
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 39,653 0.16 39,653 78
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 227,974 0.91 227,974 4
Individuals holding nominal share capital up to Rs. 1 lakh 856,035 3.42 856,035 1,531
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 539 0.00 539 1
Sub Total 1,250,000 5.00 1,250,000 1,654
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 25,000,000 100.00 25,000,000 1,657

Company Background

Cian Healthcare LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Cian Healthcare Ltd
  • BSE Code : 74131.0
  • ISIN : INE05BN01027

  • Incorporation Year

    2003

  • Registered Office

    Milkat No 3339 BNo 1 Phursungi
    From Southside CS NO 227/2, Pune,
    Maharashtra-412308

  • Telephone

    91-020-26982792

  • FAX

  • Chairman

  • Managing Director

    Suraj Zanwar

  • Company Secretary

    Bhushan Ramesh Kulkarni

  • Auditor

    S S R C A & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No S6-2,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Cian Healthcare Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Cian Healthcare 34.83 29.46 28.30 -4.14 0.00
Abbott India 27,146.85 7,217.19 6,929.05 35.73 43.78
Astrazeneca Phar 6,365.10 2,304.07 2,275.58 93.81 27.86
Glaxosmi. Pharma 2,532.60 3,932.76 3,790.20 40.46 58.17
Evonile Pharma 1,736.60 393.10 354.33 43.85 15.94
Cipla 1,400.10 20,102.60 18,979.95 42.67 13.88
Bliss GVS Pharma 625.60 773.53 729.81 40.78 12.51
Amrutanjan Healt 511.45 520.13 502.55 27.39 24.16
Fermenta Biotec. 439.00 474.15 450.25 20.49 18.77
Guj. Themis Bio. 387.70 168.25 165.82 103.66 18.05
Ambalal Sarabhai 35.67 19.52 3.94 66.06 6.77